Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.

Scott A SoefjeCorinne CarpenterKatherine CarlsonSamir AwasthiThomas S LinShuchita KailaDaniel TarjanNikhil KayalChristian KirkupTyler E WagnerKathleen S GrayShaji K Kumar

Published in: JCO oncology practice (2023)

Reduced clinic times were observed with DARA SC, indicating that use of DARA SC as a treatment option results in time savings that may free clinic resources. Furthermore, novel methods of electronic health record data extraction can provide insights that may help inform clinic resource optimization.

Keyphrases

electronic health record
multiple myeloma
primary care
clinical decision support
low dose
high dose
adverse drug